The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases.
作者信息
Fallah Jaleh, Ahluwalia Manmeet S
机构信息
Taussig Cancer Institute, Cleveland Clinic, Cleveland Ohio, OH, USA.
Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland Ohio, OH, USA.
出版信息
Ann Transl Med. 2019 Dec;7(Suppl 8):S313. doi: 10.21037/atm.2019.10.31.
Abstract
摘要
相似文献
1
The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases.
Ann Transl Med. 2019 Dec;7(Suppl 8):S313. doi: 10.21037/atm.2019.10.31.
2
Management of Brain Metastases in the New Era of Checkpoint Inhibition.
Curr Neurol Neurosci Rep. 2018 Aug 18;18(10):70. doi: 10.1007/s11910-018-0877-8.
3
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.
Vaccines (Basel). 2020 Apr 28;8(2):203. doi: 10.3390/vaccines8020203.
4
[Usefulness and limitation of immunotherapy of metastatic renal cell carcinoma with autologous lymphokine-activated killer cells and interleukin 2].
Nihon Hinyokika Gakkai Zasshi. 1991 Mar;82(3):395-404. doi: 10.5980/jpnjurol1989.82.395.
5
Outcome predictors of gamma knife radiosurgery for renal cell carcinoma metastases.
Neurosurgery. 2011 Dec;69(6):1232-9. doi: 10.1227/NEU.0b013e31822b2fdc.
6
Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous.
J Clin Oncol. 2019 Aug 10;37(23):1987-1989. doi: 10.1200/JCO.19.00639. Epub 2019 Jun 20.
7
Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
Cancer. 1998 Dec 15;83(12):2548-53.
8
Possible synergy of radiotherapy and chemo-immunotherapy in metastatic renal cell carcinoma (RCC).
Anticancer Res. 1999 Mar-Apr;19(2C):1583-7.
9
Treatment of brain metastases from renal cell cancer.
Urol Oncol. 2011 Jul-Aug;29(4):405-10. doi: 10.1016/j.urolonc.2009.07.004. Epub 2009 Oct 24.
10
Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control.
J Neurosurg. 2003 Feb;98(2):342-9. doi: 10.3171/jns.2003.98.2.0342.
引用本文的文献
1
The Complete Response of a Renal Cell Carcinoma Metastatic to Brain, Lungs, and Liver to Second-Line Nivolumab: A Case Report.
Cureus. 2022 Sep 28;14(9):e29680. doi: 10.7759/cureus.29680. eCollection 2022 Sep.
本文引用的文献
1
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
J Clin Oncol. 2019 Aug 10;37(23):2008-2016. doi: 10.1200/JCO.18.02218. Epub 2019 Jun 13.
2
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16.
3
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16.
4
Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
J Neurosurg. 2019 Jan 18;132(1):188-196. doi: 10.3171/2018.8.JNS182100. Print 2020 Jan 1.
5
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial.
J Clin Oncol. 2019 Jan 1;37(1):52-60. doi: 10.1200/JCO.18.00204. Epub 2018 Nov 8.
6
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
N Engl J Med. 2018 Aug 23;379(8):722-730. doi: 10.1056/NEJMoa1805453.
7
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.
8
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Lancet Oncol. 2018 May;19(5):672-681. doi: 10.1016/S1470-2045(18)30139-6. Epub 2018 Mar 27.
9
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
N Engl J Med. 2018 Apr 5;378(14):1277-1290. doi: 10.1056/NEJMoa1712126. Epub 2018 Mar 21.
10
Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):916-925. doi: 10.1016/j.ijrobp.2017.11.041. Epub 2017 Dec 5.
Zotero 插件